SCHEMBL24433675

SCHEMBL24433675

CC(C)(C)N/N=C(\c1ccccc1)C(C)(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.47
ALDH1A1 P00352 5/20 0.38
LMNA P02545 4/20 0.38
POLB P06746 3/20 0.36
MAPT P10636 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
CYP2C9 P11712 1/20 0.36
EPHX1 P07099 1/20 0.36
HTT P42858 1/20 0.35
ESRRG P62508 1/20 0.35
KMT2A Q03164 3/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
KDM4E B2RXH2 2/20 0.34
MEN1 O00255 2/20 0.34
GLA P06280 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
ATM Q13315 1/20 0.34
METTL3 Q86U44 1/20 0.34
TSHR P16473 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23920171 0.89 MAPT (0.40) GAAALDH1A1LMNAPOLBMAPT
SCHEMBL6546527 0.78 POLB (0.55) GAAALDH1A1LMNAPOLBMAPT
SCHEMBL24409483 0.77 GAA (0.44) GAAALDH1A1LMNAPOLBMAPT
SCHEMBL15820754 0.77 ALDH1A1 (0.47) GAAALDH1A1LMNAPOLBMAPT
SCHEMBL22512523 0.74 GAA (0.48) GAAALDH1A1LMNAMAPTHTT
SCHEMBL28541958 0.74 GAA (0.64) GAAALDH1A1LMNASMN1; SMN2HTT
SCHEMBL7071497 0.73 POLB (0.49) GAAALDH1A1LMNAPOLBMAPT
SCHEMBL9460560 0.73 ATM (0.57) GAAALDH1A1LMNAPOLBMAPT
SCHEMBL25575375 0.72 GAA (0.47) GAAALDH1A1LMNAPOLBMAPT
Fluoride SCHEMBL27890616 0.72 GAA (0.62) GAAALDH1A1LMNASMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220152215-A1 Immunoconjugates Targeting CEA BOLT BIOTHERAPEUTICS, INC. (US) 2022-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220152215-A1 Immunoconjugates Targeting CEA CD47, FCGR3B, FCGR1A GAA 815/4885ALDH1A1 1242/4885LMNA 4839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.